RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. - Wikidata - awgldk - TriplyDB

RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.

RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.

http://www.wikidata.org/entity/Q46072800

about

Mechanisms of arterial calcifications and consequences for cardiovascular function Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature Calcific aortic valve stenosis: methods, models, and mechanisms The ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling.Inflammation and the osteogenic regulation of vascular calcification: a review and perspective.Myeloid CD34+CD13+ precursor cells transdifferentiate into chondrocyte-like cells in atherosclerotic intimal calcification Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease RANKL is a downstream mediator for insulin-induced osteoblastic differentiation of vascular smooth muscle cells.PKA-induced receptor activator of NF-kappaB ligand (RANKL) expression in vascular cells mediates osteoclastogenesis but not matrix calcification Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.A current understanding of vascular calcification in CKD.Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis.Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway.Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages.The association between BMP4 gene polymorphism and its serum level with the incidence of LVH in hypertensive patients The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy Simvastatin restored vascular reactivity, endothelial function and reduced string vessel pathology in a mouse model of cerebrovascular disease.A novel biomarker of coronary atherosclerosis: serum DKK1 concentration correlates with coronary artery calcification and atherosclerotic plaques.Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability Vascular calcification: Mechanisms of vascular smooth muscle cell calcification Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis.Enhanced mineralization potential of vascular cells from SM22α-Rankl (tg) mice Atmospheric ultrafine particles promote vascular calcification via the NF-κB signaling pathway Elevated serum bone morphogenetic protein 4 in patients with chronic kidney disease and coronary artery disease Therapeutic implications of osteoprotegerin.A new role for vitamin D receptor activation in chronic kidney disease.NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL.Resistance to erythropoiesis-stimulating agents is associated with arterial microcalcification in early hemodialysis patients.RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α.Soft bone - hard arteries: a link?Vitamin D and vascular calcification in chronic kidney disease.Skeletal and extraskeletal actions of denosumab.Vascular calcification: an update on mechanisms and challenges in treatment Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy.RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy.Dietary fatty acids on aortic root calcification in mice with metabolic syndrome.Osteoporosis and cardiovascular disease: an update.

P2860

Q26821993-C5A1A2CE-1D8B-4359-9452-D45655B591B7 Q28087423-DF4029C1-8480-4520-B8A6-64F5E196D66F Q30503246-DD7EBEC1-E678-4012-90B8-ABAF277A35C9 Q33567788-DAE58050-0991-4A96-A626-B9DCB26AE4F2 Q33782750-B72D5244-9671-45C0-84F1-99D53092CD35 Q33947344-7BA2626D-EC2D-4EE5-8261-0A84A6F09F8B Q34028264-71AC37DD-F467-498A-BECD-0C876A38F871 Q34110682-1A142D46-4E0C-48C8-90A0-C06C07B93977 Q34144733-CFFE30FE-D279-47FB-938F-20F136ACA617 Q34241357-BBDED8A3-3532-47F9-822D-994D3B134488 Q34355897-E54BA23A-8F06-4E88-90DC-F6D210192471 Q34545263-CCBB1599-3270-48CE-8715-ED0581C1CFD8 Q34560277-D7512547-E62A-4912-B325-9E74C0D1B13B Q34769687-EE3AF8E6-CBD1-43C3-B33F-FA6DFD1F54B4 Q34989869-6BC43DCF-850D-4ED1-B906-565AACBA077F Q34993353-BEA000C6-7C9F-4FF9-BF29-AD92D2712CEC Q35071523-E55CCD68-CB4C-4703-B7BA-5A9A3C933EE5 Q35083231-AB09B8A3-CD8A-41C8-8148-0CED7BFC85D7 Q35123561-AA9835F5-C4F1-4E48-8721-E3BEFC982564 Q35143538-77C41D9A-0D1C-4578-8538-C229E00C1BD7 Q35211942-39C7FAB7-0867-4F94-A0B8-9A8CFC9F4402 Q35279609-7EFB90FC-75E0-426C-BB1C-965059F57F0E Q35553833-CDA44AB2-09B9-4205-98D3-E90A995BC220 Q36324316-130C0310-D829-4A32-944A-0EFA86CE7966 Q36470803-7191CCEC-AF68-4F0A-B887-6A75A00C1B56 Q36593220-81CDA3A4-117C-4D0B-B2F4-81BB3AD02ED2 Q36675042-5D44B3D5-7C5F-4D1F-A2D1-626F3582FC1E Q37368570-55A603E8-05C4-4C0C-91CE-BAA5D7DAC698 Q37558961-E79E54E7-57F7-437A-806A-AECDE476F86F Q37633121-0575AC40-4666-4197-8055-DCD06B3E5B27 Q37687219-C44E81BD-AF2A-4F76-A368-BF4A27BC2EF3 Q37727115-FE68B7D6-7A4B-4F5A-9F94-8AFB10C98C49 Q37892299-9DE30DFC-B108-4CDD-B0F9-5612B4A6F425 Q37892311-AD9413CD-D28E-48B6-8CD6-321A726F8660 Q38009712-2BC59155-E121-4719-88D1-AF5E92E365CB Q38086058-D2A1CE9F-9849-4F3C-A7AC-34AEDE5C6F6A Q38148953-D9287E29-D4FD-409B-AAE8-1B5F878A7083 Q38238914-03F6FBF9-EDB7-4FDE-B834-C000753F03FB Q38288785-E6FC550C-50B1-4AA3-A281-0E3821E4AAC8 Q38513410-A401BA57-EB5C-41D4-BD92-C8FB36D0F006

P2860

RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.

http://www.wikidata.org/entity/Q46072800

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

RANKL increases vascular smoot ...... a RANK-BMP4-dependent pathway.

@en

RANKL increases vascular smoot ...... a RANK-BMP4-dependent pathway.

@nl

type

label

RANKL increases vascular smoot ...... a RANK-BMP4-dependent pathway.

@en

RANKL increases vascular smoot ...... a RANK-BMP4-dependent pathway.

@nl

prefLabel

RANKL increases vascular smoot ...... a RANK-BMP4-dependent pathway.

@en

RANKL increases vascular smoot ...... a RANK-BMP4-dependent pathway.

@nl

P1433

Q46072800-8902C7B1-A0F3-42C8-B446-5742F66A1B01

P1476

Q46072800-285001AF-B0FB-46E5-8721-47C3401CBAF1

P2093

Q46072800-04875A2C-6CBB-4AA8-BBFA-509FED81336D

Q46072800-0BA8BF59-8984-4A25-B849-5D9E74684ADA

Q46072800-0BB036B7-BFCB-426D-A533-10B8827568F4

Q46072800-0DF9D2E2-CCAB-4A53-BF69-BBAD47158E99

Q46072800-23DE7DCD-4F5F-4D3F-943C-CDF0E3A2A832

Q46072800-63B5D83B-C0A7-4BEE-AA0A-43AC541E3D20

Q46072800-BE76DDF1-2477-406F-8A43-8D5D9CC8811A

P304

Q46072800-6466C999-E1CA-41F3-B4E9-9A620C21DEE5

P31

Q46072800-CF700383-5303-4CD9-A3A1-F53732AD92FE

P356

Q46072800-DDA93954-8751-4A4F-B977-FB23F53475A0

P433

Q46072800-7AA9FD4B-6258-4A1B-AA08-CABBC455274D

P478

Q46072800-A4A502ED-57FD-4BDE-8A4B-DE6AD6816BFC

P50

Q46072800-02121A53-904A-41B3-8503-1066FDA76062

Q46072800-17B99DC2-C69F-4471-9E59-7C391735BEC1

P577

Q46072800-65032FDD-B66F-4B5A-B961-1F093284F032

P698

Q46072800-B2236E89-95B0-46B7-8FF3-D429BE30AE7F

P356

CIRCRESAHA.108.189001

P1433

Circulation Research

P1476

RANKL increases vascular smoot ...... a RANK-BMP4-dependent pathway.

@en

P2093

Anna Cardus

http://www.w3.org/2001/XMLSchema#string

Blai Coll

http://www.w3.org/2001/XMLSchema#string

Elvira Fernandez

http://www.w3.org/2001/XMLSchema#string

Eva Parisi

http://www.w3.org/2001/XMLSchema#string

Petya Valcheva

http://www.w3.org/2001/XMLSchema#string

Sara Panizo

http://www.w3.org/2001/XMLSchema#string

Susana López-Ongil

http://www.w3.org/2001/XMLSchema#string

P304

1041-1048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.108.189001

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Jose M Valdivielso

P577

2009-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19325147

http://www.w3.org/2001/XMLSchema#string